Visiopharm Expands Their Comprehensive Digital Pathology Integration List to Include The Philips Scanner
Visiopharm a leading
provider of Quantitative Digital Pathology solutions announces the expansion of
their comprehensive digital pathology integration list to include support for
the Philips Digital Pathology solution.
October 29, 2012 Hørsholm, Denmark — Visiopharm a leading provider of Quantitative
Digital Pathology solutions announced today the expansion of their
comprehensive digital pathology integration list to include support for the Philips Digital Pathology solution for
Visiopharm has the most complete integration list on the market;
with support for all leading digital pathology
scanners and software integration with several digital
pathology data management solutions. Integration is available with Aperio,
Hamamatsu, Leica, MetaSystems, Olympus, PathXL, 3DHistech, and now
Philips. Johan Doré, Chief Technology
Officer at Visiopharm, stated “Our
commitment to integration provides digital pathology customers with the
flexibility to choose the scanner and data management software that best fit
their needs without sacrificing workflow for image analysis.”
Visiopharm customers can quickly and easily expand their
quantitative power with the APPCenter; featuring over 40 ready-to-use
Analysis Protocol Packages (APPs) that can be tested free of charge. APPs are purchased for a one time, low fixed
cost and will work with both Visiopharm's DeployedAnalysis and CloudAnalysis solutions. CloudAnalysis includes pay-as-you-go access
to all Visiopharm analysis software, including TissuemorphDP™ and VisiomorphDP™ in the Cloud.
Visiopharm will be exhibiting at Pathology
Visions 2012 on October 28-31, 2012 in Baltimore, MD. Please visit their booth #26 & #27 to
learn more about their quantitative digital pathology solutions.
Over the past 10 years, Visiopharm image analysis and
stereology software has become the preferred Quantitative Digital Pathology
solution for leading biopharmaceutical companies, clinical researchers, and
academic researchers all over the world. Visiopharm has more than 300 deployed
systems worldwide and a large network of distribution and support partners, and
is featured in over 400 scientific publications.